A New Era for Treating and Preventing Asthma Exacerbations

A New Era for Treating and Preventing Asthma Exacerbations

Learning Objectives

After participating in this activity, participants should be able to:

  1. Explain the potential for adverse outcomes of systemic corticosteroid overuse and SABA monotherapy for asthma treatment.
  2. Describe the benefits of ICS use with a fast-acting bronchodilator to prevent exacerbations in mild or moderate asthma.
  3. Apply asthma management principles consistent with GINA recommendations for asthma care.
  4. Discuss prescribing information and clinical evidence of a newly approved, combination, inhaled therapy for prevention and treatment of asthma exacerbations.


Primary Care Education Consortium is accredited by the ACCME to provide continuing medical education for physicians.

Primary Care Education Consortium designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release/Expiration Dates

Credit is available from October 26, 2023, to October 14, 2024. To receive CME credit and a transcript for participation, complete the post-survey after viewing the activity.

About the Authors/Faculty Disclosures

Dr. Lugogo, Associate Professor of Internal Medicine, is the Division of Pulmonary & Critical Care Medicine’s Asthma Program Director at the University of Michigan. Dr. Lugogo completed her Medical Degree at the Medical College of Virginia, Richmond, VA. She completed her Internal Medicine Residency at Wake Forest University, Winston-Salem, NC. After she completed her Pulmonary & Critical Care Medicine Fellowship at Duke University, she rose to Assistant Professor. At Duke, Dr. Lugogo served as the Medical Director of the Duke Asthma Allergy and Airway Center and Director of the Asthma Clinical Trials Group and Pulmonary Clinical Research Unit. She joined the University of Michigan Pulmonary & Critical Care Medicine faculty August, 2017.

Dr. Skolnik is a practicing family physician who teaches residents and medical students at Abington Family Medicine. He is a Professor of Family and Community Medicine at Temple University School of Medicine, and Associate Director of the Family Medicine Residency Program at Abington Memorial Hospital. He graduated from Emory University School of Medicine and did his residency training at Thomas Jefferson University Hospital. A frequent author and lecturer, he currently coordinates educational podcasts for the American Diabetes Association, the Infectious Disease Society of America, and Family Practice and Internal Medicine News. He has also worked with large organizations including the CDC, the American Thoracic Society, and the American Academy of Family Physicians.

Dr. Yawn is a family physician and clinical researcher with 14 years’ experience as a full time rural physician and 25 years as a clinical researcher. She has authored over 350 peer reviewed published manuscripts, 3 books, and numerous book chapters in a variety of topics from rural primary care to chronic respiratory diseases, primarily asthma and COPD. She was a member of the 2007 Expert Review Panel that developed the current asthma care guidelines and the WHO panel that developed the International Primary Care Respiratory guidelines for obstructive lung disease. She has served on 6 other national evidence based guideline panels in addition to the one for asthma, most recently co-chairing the NHLBI Sickle Cell Disease guideline panel. She developed a research department in a large primary care based medical group in Rochester and SE Minnesota where she led studies funded by the National Institutes of Health, the Agency for HealthCare Quality and Research, the Centers for Disease Control and Prevention, and private foundations. She has recently retired from the position as Director of Research at the Olmsted Medical Center but continues working with other research around the US and is participating in educational work directed to primary care physicians and other clinicians.

Primary Care Education Consortium adheres to the conflict-of-interest policy of the ACCME and the AMA. All individuals in a position to control the content disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty. Only participants who have no conflict of interest or who agree to an identified mitigation process prior to their participation were involved in the CME activity.

All relevant financial relationships have been mitigated for this activity.

Njira Lugogo, MD, MS
Dr. Njira Lugogo discloses that she does research for and serves on advisory boards for Regeneron/Sanofi, Novartis, and Genentech. She does research for Janssen and serves as a consultant for Amgen. In addition, these are the companies for whom she does research, serves on an advisory board, serves as a consultant, and does talks: AstraZeneca, GSK and Teva.

Neil Skolnik, MD
Dr. Neil Skolnik discloses that he receives research support, serves on the advisory board as a consultant and serves as a speaker for: AstraZeneca, Sanofi Pasteur, Bayer, Novo Nordisk and GSK. He receives research support and serves on the advisory board as a consultant for Sanofi Diabetes. He serves on the advisory board as a consultant and as a speaker for Astellas, Lilly, and Boehringer-Ingelheim/Lilly. He serves as a speaker for Teva and Heartland, and is an advisory board member and consultant for Genentech, Abbott, and Idorsia.

Barbara Yawn, MD, MSc, FAAFP

Dr. Barbara Yawn discloses that she serves as a consultant and is on the advisory board for GlaxoSmithKline, Boehringer Ingelheim, Teva, and AstraZeneca. She serves as a consultant for Regeneron. 

Austin Ulrich, PharmD, editorial support, and Dr. Michael Hanak, CME reviewer, have no disclosures to report.


This activity is sponsored by the Primary Care Education Consortium and the Primary Care Respiratory Group.


This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.


The authors received writing/editorial support in the preparation of video and manuscript content from Austin Ulrich, PharmD, of Primary Care Education Consortium. The content for this webinar was produced according to the policies of the Accreditation Council for Continuing Medical Education (ACCME).

Contact Information

Primary Care Education Consortium
Phone: 704-752-0257
Email: nwilliams@pceconsortium.org

Published October 26, 2023

Recent Articles